Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
Protests by thousands of pro-democracy activists in Leh and Kargil districts on 16 March, demanding, among other things, statehood for...
Read moreDetails
The ongoing war between the US-Israel combine and Iran has unexpectedly turned out to be a windfall for Russia. In...
Read moreDetails
The widening conflict in West Asia is beginning to cast a shadow over India’s economic outlook. The country’s heavy dependence...
Read moreDetails
On 4 November 2013, then Prime Minister Manmohan Singh spoke to over 120 heads of Indian missions and outlined the...
Read moreDetails
